Replimune stockREPL
Replimune trades at $20.02, 5.8% below its 52-week high (Nov 3, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +106.0% year to date, +133.3% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 2, 2027.
Ratings, candles, signals and the screener for REPL — after you log in
Open the terminalFrequently asked questions about Replimune
What is the Replimune stock price?
At the close on Nov 5, 2026: $20.02 (−3.24% on the day). 52-week high: $21.26 on Nov 3, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Replimune report earnings?
The next quarterly report is on Feb 2, 2027. Last quarter, earnings per share changed +40% year over year, revenue 0%.
Does Replimune pay dividends?
No, Replimune does not pay dividends.
Where does Replimune trade and how to buy it?
Ticker REPL, exchange Nasdaq, listed since 2018. You can buy it through a broker with access to US exchanges.
Should I buy Replimune now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for REPL are in the terminal after you log in.